GGrantIndex
Sort

130,381 grants matching hiv

Establishment of HIV infection and ensuing HostiVirus interactions

$807,701
James Ivan Mullins · University Of Washington · P01 · FY2012 · AI

Characterization of HIV-1 IgA bNAbs and ADCP function

$807,667
Xueling Wu · Boston Medical Center · R01 · FY2025 · AI

Developmental Effects of Prenatal Cocaine Exposure

$807,654
Michael Lewis · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2009 · DA

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

$807,629
Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2022 · DK

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

$807,629
Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2021 · DK

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

$807,629
Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2020 · DK

SHIV-guided design of novel HIV-1 fusion peptide immunogens

$807,628
George M Shaw · University Of Pennsylvania · R01 · FY2024 · AI

Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction

$807,613
Lishomwa C Ndhlovu · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AG

Creating high-resolution, epitope-focused vaccines

$807,602
Peter S Kim · Stanford University · DP1 · FY2022 · AI

Development of a Self Inactivating, Highly Effective TB Vaccine

$807,595
Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI

Immunopathogenesis of HIV-associated pulmonary hypertension

$807,583
Karen A Norris · University Of Georgia · R01 · FY2018 · HL

(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV

$807,549
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2025 · CA

Comprehensive Translational Science Analytics Tools for the Global Health Agenda

$807,500
Donna L Spiegelman · Harvard School Of Public Health · DP1 · FY2016 · ES

Comprehensive Translational Science Analytics Tools for the Global Health Agenda

$807,500
Donna L Spiegelman · Harvard School Of Public Health · DP1 · FY2014 · ES

Comprehensive Translational Science Analytics Tools for the Global Health Agenda

$807,500
Donna L Spiegelman · Harvard School Of Public Health · DP1 · FY2017 · ES

Comprehensive Translational Science Analytics Tools for the Global Health Agenda

$807,500
Donna L Spiegelman · Harvard School Of Public Health · DP1 · FY2015 · ES

Structural definition of CD4-induced HIV-1 Env conformational changes required for infection

$807,497
Priyamvada Acharya · Duke University · R01 · FY2025 · AI

Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV

$807,482
John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK

Core B - Developmental

$807,453
Ira B Wilson · Miriam Hospital · P30 · FY2021 · AI

(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV

$807,377
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2021 · CA

Targeting IgM Memory to Establish Protective B Cell Responses to HIV

$807,376
James J Kobie · University Of Rochester · R01 · FY2017 · AI

When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective

$807,340
Anna Bershteyn · New York University School Of Medicine · R01 · FY2022 · MH

Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques

$807,319
Rebecca Terilli Veenhuis · Johns Hopkins University · R01 · FY2021 · MH

Central Control and Neuroinflammatory Mechanisms of Locomotion in Older Adults with HIV

$807,312
Roee Holtzer · Albert Einstein College Of Medicine · R01 · FY2024 · NS

(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV

$807,310
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2023 · CA